RNA-interference (RNAi) Market 2019: Global Industry Trends, Growth, Innovation, Sales Revenue by Regional Forecast to 2023

RNA-interference (RNAi)

The report RNA-interference (RNAi) Market 2019 provides an in-depth analysis of all market dynamics including drivers and restraints, and trends and opportunities. Important factors supporting growth across various is also provided. Using the industrial figures, the market finds growth figures between the forecast period from 2019 to 2024. In order to present an executive-level model of the market and its future perspectives, the report presents a clear segmentation based on different parameters. The factors that affect these segments are also discussed in detail in the report. The report RNA-interference (RNAi) Market provides market intelligence on the different segments of the Healthcare category.

Get Sample Copy of Report @


RNA-interference (RNAi) market manufacturers are covered in this report, with sales, market share, revenue for each company: Global RNA-interference (RNAi) market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including

  • Alnylam Pharmaceuticals
  • Arcturus Therapeutics
  • Arrowhead
  • Dicerna Pharmaceuticals
  • Ionis Pharmaceuticals Inc.
  • Merck & Co. Inc. (Sigma Aldrich)
  • Qiagen NV
  • Thermo Fisher Scientific Inc.
  • Quark Pharmaceuticals Inc.
  • Silence Therapeutics PLC
  • Phio Pharmaceuticals Corp., And many more…

    About RNA-interference (RNAi) Market:

    The RNA-interference (RNAi) market is expected to witness a CAGR of 20.2% during the forecast period. Certain factors that are driving the market growth include the increasing number of applications in molecular diagnostics, particularly in cancer and improving synthetic delivery carriers and chemical modifications to RNA.Cancer diagnosis and treatment is currently undergoing a shift with the incorporation of RNAi techniques in personalized medicine and molecular diagnostics. The availability of high throughput techniques for the identification of altered cellular molecules and metabolites allows the use of RNAi techniques in various cancer diagnosis and targeting approaches. For diagnostic purposes, small interfering RNAs (siRNA) or microRNAs (miRNA) can be utilized. The commercial availability of siRNAs to silence virtually any gene in the human genome is dramatically accelerating the pace of molecular diagnosis and biomedical research. Thus, increasing the application of RNAi in molecular diagnosis and its viability as a therapeutic technique is expected to drive the growth of the RNAi market during the forecast period.However, in recent years, there has been a decline in FDA drug approval rates. Getting FDA approval for a new drug has become extremely challenging. It approved less than half the number of new drugs in 2016 (19 so far) when compared to 2015 (45 total) and 2014 (41 total). Hence, despite the large investments, there has been a decline in the number of innovative drugs manufactured. FDA explains manufacturing standards and other complying issues as the major reasons for this declining trend. This can impede the growth of the RNAi therapeutics, especially since the miRNAs and siRNAs fall into the relatively new field of genetic medicine, wherein they may require more intensified clinical trials. The highly extensive clinical trials effectively result in low approval rates of drugs. This would mean that the stringent guidelines will be a major restraint for the growth of the market.

    Scope of the Report:
    RNA interference is a biological process in which the RNA molecules are observed to inhibit gene expression or translation, by neutralizing the targeted mRNA molecules. Earlier, RNAi was identified by other names, such as co-suppression, post-transcriptional gene silencing (PTGS), and quelling. The extensive study of each of these apparently different processes clarified that the identity of these phenomena were all in fact RNAi.

    Key Benefits:

    • The RNA-interference (RNAi) report will help to develop Business Strategies by understanding the trends shaping and driving the RNA-interference (RNAi) market
    • To establish sales and marketing efforts by identifying the best opportunities for RNA-interference (RNAi) market
    • To recognize the future market competition in the RNA-interference (RNAi) market. 

    RNA-interference (RNAi) Market’s Top Regions Covers in this Report: Data type includes capacity, production, market share, price, revenue, cost, gross, gross margin, growth rate, consumption, import, export and manufacturing process, cost structure, marketing channel are also analyzed in this report.

    United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, GCC, South Africa, Brazil, Argentina.

    Have any Query Regarding the RNA-interference (RNAi) Market Report? Contact us: https://www.marketreportsworld.com/enquiry/pre-order-enquiry/13486506

    Report Highlights:

    • Market Dynamics – Drivers and Restraints
    • Market Trends
    • SWOT Analysis and Porter’s Five Forces Analysis
    • Company Analysis.

    The RNA-interference (RNAi) report offers:

    • Manufacturers, Regions, Types, and Applications
    • Market size and share for the geographical level segments
    • Market size, and share, opportunity, growth trend analysis of the top manufactures player
    • Strategic recommendations for the new entrants for business growth
    • RNA-interference (RNAi) market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
    • Competitive landscaping mapping the key growth trends
    • Manufactures describing with detailed strategies, financials, and current developments

    Price of Report $ 4250 (Single User License)

    Purchase Full Report at: –


    Table of Content:

    1.1 Study Deliverables
    1.2 Study Assumptions
    1.3 Scope of the Study



    4.1 Market Overview
    4.2 Market Drivers
    4.2.1 Increasing Number of Applications in Molecular Diagnostics, Particularly in Cancer
    4.2.2 Improving Synthetic Delivery Carriers and Chemical Modifications to RNA
    4.3 Market Restraints
    4.3.1 Stringent FDA Regulations and Changing Reimbursement Environment
    4.3.2 Unstable Potentially Immunogenic Nature of RNA
    4.4 Porters Five Forces Analysis
    4.4.1 Threat of New Entrants
    4.4.2 Bargaining Power of Buyers/Consumers
    4.4.3 Bargaining Power of Suppliers
    4.4.4 Threat of Substitute Products
    4.4.5 Intensity of Competitive Rivalry

    5.1 Application
    5.1.1 Drug Discovery and Development
    5.1.2 Therapeutics Oncology Ocular Disorders Respiratory Disorders Hepatitis B and C Autoimmune Hepatitis Neurological Disorders Other Therapeutics
    5.1.3 Other Applications
    5.2 Geography
    5.2.1 North America US Canada Mexico
    5.2.2 Europe Germany UK France Italy Spain Rest of Europe
    5.2.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
    5.2.4 Middle East & Africa GCC South Africa Rest of Middle East & Africa
    5.2.5 South America Brazil Argentina Rest of South America

    6.1 Company Profiles
    6.1.1 Alnylam Pharmaceuticals
    6.1.2 Arcturus Therapeutics
    6.1.3 Arrowhead
    6.1.4 Dicerna Pharmaceuticals
    6.1.5 Quark Pharmaceuticals Inc.
    6.1.6 Ionis Pharmaceuticals Inc.
    6.1.7 Merck & Co. Inc. (Sigma Aldrich)
    6.1.8 Silence Therapeutics PLC
    6.1.9 Qiagen NV
    6.1.10 Phio Pharmaceuticals Corp.
    6.1.11 Thermo Fisher Scientific Inc.


    About Us:

    Market reports world is an upscale platform to help key personnel in the business world in strategizing and taking visionary decisions based on facts and figures derived from in-depth market research. We are one of the top report resellers in the market, dedicated to bringing you an ingenious concoction of data parameters.

    Contact Us:

    Name: Mr. Ajay More

    Organization: Market Reports World

    Email: [email protected]

    Phone: +1 408 520 9750/+44 203 239 8187